Individuals with cancer who get COVID-19 are more likely to have severe illness and higher death rates compared to the general public. This study aims to help prevent worse outcomes in patients with cancer and COVID-19

Bladder cancer is more aggressive and more advanced in South Texas residents ­than in many parts of the country, a study by the Mays Cancer Center indicates.

With the COVID-19 vaccine now here, hopes for stopping the spread and returning to normal life are on the rise. But many people are still hesitant to receive the vaccine, with concerns about safety and efficacy. In this series, “Your COVID-19 Vaccine Questions Answered,” our experts explain why getting the vaccine is not only safe, but also the best way to protect yourself and the people you love.

UT Health San Antonio and its Mays Cancer Center will receive a $6 million award from the Cancer Prevention and Research Institute of Texas to recruit Alexander Mazin, PhD, a senior, highly accomplished biochemist and cancer biologist currently at Drexel University College of Medicine.